跳至主要内容
临床试验/KCT0006797
KCT0006797
已完成
未知

A comparison of respiratory effects of propofol and remimazolam during procedural sedation: a randomized controlled trial.

Samsung Medical Center0 个研究点目标入组 70 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Not Applicable
发起方
Samsung Medical Center
入组人数
70
状态
已完成
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
2022年5月2日
最后更新
3年前
研究类型
Interventional Study
性别
All

研究者

入排标准

入选标准

  • 1\) Patients with the ASA PS class I\~III
  • 2\) Patients scheduled for the insertion of central venous access port devices for the delivery of chemotherapy under monitored anesthetic care(MAC)

排除标准

  • 1\) Patients with severe cognitive dysfunction
  • 2\) Body Mass Index \> 35 kg / m 2 or \<18\.5 kg / m 2
  • 3\) Severe liver disease
  • 4\) Neuromuscular disease or mental illness kidney disease (GRF \<30 or under hemodialysis)
  • 5\) Those diagnosed with metabolic diseases
  • 6\) Drug addiction or alcohol addiction
  • 7\) People who have contraindications to benzodiazepine, sevoflurane, or propofol
  • (Patients who have allergies to drugs or have a history of hypersensitivity reactions)
  • 8\) acute narrow\-angle glaucoma
  • 9\) intolerance to galactose, deficiency of Lapp lactase, glucose\-galactose absorption disorder

结局指标

主要结局

未指定

相似试验